Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought Instead
On Monday, Cathie Wood’s ARK Invest sold 4,520 shares of Meta Platforms ($META) through its ARK Innovation ETF ($ARKK). Based on Meta’s closing pri...
Intellia Therapeutics Inc. (NTLA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 16,875,684 | $285,536,575 | +17% | 1.85% |
| 2. | D E Shaw D. E. Shaw | 6,443,323 | $109,021,025 | +13% | 0.05% |
| 3. | RA Capital Management Peter Kolchinsky | 4,526,926 | $76,595,588 | 0.67% | |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,280,760 | $55,510,459 | +135% | 0.02% |
| 5. | Contrarius Investment Management Stephen Mildenhall | 1,955,228 | $33,082,458 | +3% | 1.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.35 | 150,000 | $1,402,500.00 | 207,453 | 2026-01-05 | Filing | |
| $10.03 | 100,000 | $1,003,000.00 | 134,693 | 2025-08-20 | Filing | |
| $15.50 | 4,250 | $65,875.00 | 7,500 | 2019-03-06 | Filing | |
| $16.00 | 3,250 | $52,000.00 | 3,250 | 2019-03-06 | Filing | |
| $18.00 | 58,534 | $1,053,612.00 | 2,662,180 | 2016-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.43 | 1,864 | $23,169.52 | 65,022 | 2026-10-02 | Filing | |
| $13.00 | 2,785 | $36,205.00 | 1,147,064 | 2026-08-21 | Filing | |
| $12.60 | 19,890 | $250,614.00 | 1,149,849 | 2026-08-20 | Filing | |
| $11.25 | 8,111 | $91,248.75 | 148,175 | 2026-07-22 | Filing | |
| $16.78 | 2,641 | $44,315.98 | 66,886 | 2026-07-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 266,169 | $3,209,998 | 0.09% | |
| 2. | 22,737 | $286,486 | 0% | |
| 3. | 13,309 | $160,507 | 0% | |
| 4. | 3,887 | $46,877 | 0% | |
| 5. | 2,144 | $25,857 | 0% |
News See All
Cathie Wood Sells $28.6M of Alphabet Stock and Buys $26.4M of Meta Shares. What Else Is She Buying?
Cathie Wood’s ARK Invest bought 43,091 shares of Meta Platforms ($META) worth about $26.4 million on Wednesday, September 9. The firm also added ab...
Intellia Therapeutics (NTLA) Secured a Facility for Up to $400M. Is It Worth the Cost?
Intellia Therapeutics, Inc. (NASDAQ:NTLA) entered a five-year senior secured credit facility with OrbiMed for up to $400 million and drew $75 million at closing.
Is Intellia Therapeutics, Inc. (NTLA) A Good Stock To Buy Now?
Is NTLA a good stock to buy? We came across a bullish thesis on Intellia Therapeutics, Inc. on Markman Capital Insight’s Substack. In this article, we will summarize the bulls’ thesis on NTLA.
10 Stocks Stealing the Spotlight from Wall Street Giants
Ten stocks started the trading week jumping by double-digits and mirroring the highly optimistic broader market, thanks to the US and Iran’s deal to end the war.
Intellia (NTLA) Rockets 13% Ahead of Phase 3 Lonvo-Z Study Update
Intellia Therapeutics Inc. (NASDAQ:NTLA) is one of the 9 Stocks Crushing the Market With Surging Returns.
9 Stocks Crushing the Market With Surging Returns
Nine stocks posted strong gains on Thursday, bucking a mixed performance in the broader market, driven by positive company-specific developments that boosted buying appetite.
10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now
In this article, we will discuss the 10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds.
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
We came across a bullish thesis on Intellia Therapeutics, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on NTLA.
Hedge Fund Resource Center